| |  Online-Ressource |
|---|
| Verfasst von: | Tanner, Michael Christopher [VerfasserIn]  |
|---|
| | Heller, Raban [VerfasserIn] |
|---|
| | Westhauser, Fabian [VerfasserIn] |
|---|
| | Miska, Matthias [VerfasserIn] |
|---|
| | Ferbert, Thomas [VerfasserIn] |
|---|
| | Fischer, Christian [VerfasserIn] |
|---|
| | Gantz, Simone [VerfasserIn] |
|---|
| | Schmidmaier, Gerhard [VerfasserIn] |
|---|
| | Haubruck, Patrick [VerfasserIn] |
|---|
| Titel: | Evaluation of the clinical effectiveness of bioactive glass (S53P4) in the treatment of non-unions of the tibia and femur |
|---|
| Titelzusatz: | study protocol of a randomized controlled non-inferiority trial |
|---|
| Verf.angabe: | Michael C. Tanner, Raban Heller, Fabian Westhauser, Matthias Miska, Thomas Ferbert, Christian Fischer, Simone Gantz, Gerhard Schmidmaier and Patrick Haubruck |
|---|
| E-Jahr: | 2018 |
|---|
| Jahr: | 30 May 2018 |
|---|
| Fussnoten: | Gesehen am 15.06.2018 |
|---|
| Titel Quelle: | Enthalten in: Trials |
|---|
| Ort Quelle: | London : BioMed Central, 2000 |
|---|
| Jahr Quelle: | 2018 |
|---|
| Band/Heft Quelle: | 19(2018) Artikel-Nummer 299, 9 Seiten |
|---|
| ISSN Quelle: | 1468-6694 |
|---|
| | 1745-6215 |
|---|
| Abstract: | Treatment of non-union remains challenging and often necessitates augmentation of the resulting defect with an autologous bone graft (ABG). ABG is limited in quantity and its harvesting incurs an additional surgical intervention leaving the risk for associated complications and morbidities. Therefore, artificial bone graft substitutes that might replace autologous bone are needed. S53P4-type bioactive glass (BaG) is a promising material which might be used as bone graft substitute due to its osteostimulative, conductive and antimicrobial properties. In this study, we plan to examine the clinical effectiveness of BaG as a bone graft substitute in Masquelet therapy in comparison with present standard Masquelet therapy using an ABG with tricalciumphosphate to fill the bone defect. |
|---|
| DOI: | doi:10.1186/s13063-018-2681-9 |
|---|
| URL: | Kostenfrei: Volltext ; Verlag: http://dx.doi.org/10.1186/s13063-018-2681-9 |
|---|
| | Kostenfrei: Volltext: https://doi.org/10.1186/s13063-018-2681-9 |
|---|
| | DOI: https://doi.org/10.1186/s13063-018-2681-9 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Bioactive glass |
|---|
| | Bone grafting |
|---|
| | Bone regeneration |
|---|
| | Masquelet therapy |
|---|
| | Non-union |
|---|
| | Pseudarthrosis |
|---|
| | S53P4 |
|---|
| K10plus-PPN: | 1576401545 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
| |
|
|---|
| | |
|---|
| Lokale URL UB: |  Zum Volltext |
|---|
Evaluation of the clinical effectiveness of bioactive glass (S53P4) in the treatment of non-unions of the tibia and femur / Tanner, Michael Christopher [VerfasserIn]; 30 May 2018 (Online-Ressource)
